Viewing Study NCT00080405


Ignite Creation Date: 2025-12-25 @ 3:20 AM
Ignite Modification Date: 2026-02-23 @ 1:11 AM
Study NCT ID: NCT00080405
Status: COMPLETED
Last Update Posted: 2009-03-27
First Post: 2004-03-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Repeat-Dose Pharmacokinetics and Pharmacodynamics of Bortezomib in Patients With Relapsed Multiple Myeloma
Sponsor: Millennium Pharmaceuticals, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Relapsed View
None Multiple Myeloma View
None Pharmacokinetic View
None Pharmacodynamic View